Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
They contain the active ingredient tirzepatide, which is a newer type of medication known as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
O remdio faz parte de uma nova gerao de medicamentos para o tratamento de diabetes tipo 2 que atuam em receptores de hormnios produzidos pelos intestinos, responsveis pela sensao de saciedade, e demonstraram potencial para levar perda de peso em pacientes obesos
Protein Concentration Determination Determine the protein concentration of the cell lysate by performing a Bradford Assay
Is IV therapy safe for everyone
Clinical Trial Dosing Range tested: Doses from 0.3 mg up to 4.5 mg weekly have been investigated
While more detailed studies and clinical trials are pending, the above preliminary study suggests that the peptide may indirectly help to increase lifespan of functional cells
